DK0891426T3 - Humant bikunin - Google Patents

Humant bikunin

Info

Publication number: DK0891426T3
Authority: DK; Denmark
Prior art keywords: beak; human; human beak
Prior art date: 1996-03-11

Application number

DK97915029T

Other languages

English (en)

Inventor

Daniel K Muller

Paul P Tamburini

Gary Davis

Katherine A Delaria

Christopher W Marlor

Original Assignee

Bayer Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-11

Filing date

1997-03-10

Publication date

2006-10-02

1997-03-10 Application filed by Bayer Corp filed Critical Bayer Corp

2006-10-02 Application granted granted Critical

2006-10-02 Publication of DK0891426T3 publication Critical patent/DK0891426T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
- C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hematology (AREA)
Zoology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Wood Science & Technology (AREA)
Heart & Thoracic Surgery (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Physics & Mathematics (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Plant Pathology (AREA)

DK97915029T 1996-03-11 1997-03-10 Humant bikunin DK0891426T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US1310696P	1996-03-11	1996-03-11
US1979396P	1996-06-14	1996-06-14
US72525196A	1996-10-04	1996-10-04

Publications (1)

Publication Number	Publication Date
DK0891426T3 true DK0891426T3 (da)	2006-10-02

Family

ID=27359773

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97915029T DK0891426T3 (da)	1996-03-11	1997-03-10	Humant bikunin

Country Status (27)

Country	Link
US (3)	US6583108B1 (da)
EP (1)	EP0891426B1 (da)
JP (2)	JP3469584B2 (da)
KR (1)	KR100356956B1 (da)
AR (3)	AR006188A1 (da)
AT (1)	ATE328083T1 (da)
AU (1)	AU716923B2 (da)
BR (1)	BR9708021A (da)
CA (1)	CA2247888A1 (da)
CO (1)	CO4600683A1 (da)
DE (1)	DE69735996T2 (da)
DK (1)	DK0891426T3 (da)
ES (1)	ES2263174T3 (da)
HR (1)	HRP970144B1 (da)
HU (1)	HU226419B1 (da)
ID (1)	ID16224A (da)
IL (1)	IL126115A (da)
IN (1)	IN192874B (da)
MY (1)	MY120693A (da)
NZ (1)	NZ331540A (da)
PA (1)	PA8426301A1 (da)
PL (1)	PL188387B1 (da)
PT (1)	PT891426E (da)
SV (1)	SV1997000018A (da)
TR (1)	TR199801794T2 (da)
WO (1)	WO1997033996A2 (da)
YU (1)	YU8997A (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6057287A (en)	1994-01-11	2000-05-02	Dyax Corp.	Kallikrein-binding "Kunitz domain" proteins and analogues thereof
EP0758682B1 (en) *	1995-07-24	2004-05-12	Mitsubishi Chemical Corporation	Hepatocyte growth factor activator inhibitor
ES2263174T3 (es)	1996-03-11	2006-12-01	Bayer Corporation	Bikunina humana.
WO1998033920A2 (en) *	1997-01-31	1998-08-06	Human Genome Sciences, Inc.	Tissue factor pathway inhibitor-3
WO2000037099A2 (en) *	1998-12-22	2000-06-29	Bayer Aktiengesellschaft	Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
WO2000051624A2 (en)	1999-03-05	2000-09-08	The Trustees Of University Technology Corporation	Methods and compositions useful in inhibiting apoptosis
AU3511500A (en)	1999-03-05	2000-09-21	Trustees Of University Technology Corporation, The	Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
US20040235715A1 (en) *	1999-11-12	2004-11-25	Bayer Corporation	Method of producing glycosylated bikunin
IL140994A (en) *	2000-05-15	2005-12-18	Bayer Ag	Urinary trypsin inhibitor assay containing a chelating agent
IL140993A0 (en)	2000-05-15	2002-02-10	Bayer Ag	Trypsin substrate and diagnostic device, and method of using same
US6955921B2 (en) *	2001-04-30	2005-10-18	Bayer Corporation	Trypsin substrate and diagnostic device, and method of using same
EP1539985A4 (en) *	2001-11-05	2006-06-28	Curagen Corp	THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES, AND METHODS OF USE
DE60333758D1 (de)	2002-06-07	2010-09-23	Dyax Corp	Prevention und Verringerung von Ischemia
US7153829B2 (en)	2002-06-07	2006-12-26	Dyax Corp.	Kallikrein-inhibitor therapies
SI1583562T1 (sl)	2003-01-06	2011-10-28	Angiochem Inc	AngioPep-1, sorodne spojine in njihove uporabe
US8460243B2 (en)	2003-06-10	2013-06-11	Abbott Diabetes Care Inc.	Glucose measuring module and insulin pump combination
US7244616B2 (en)	2003-06-27	2007-07-17	Bayer Pharmaceuticals Corporation	Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
US7722536B2 (en)	2003-07-15	2010-05-25	Abbott Diabetes Care Inc.	Glucose measuring device integrated into a holster for a personal area network device
EP1660094A4 (en)	2003-08-26	2009-09-16	Univ Colorado	INHIBITORS OF SERINE PROTEASE ACTIVITY AND USES THEREOF IN METHODS AND PREPARATIONS FOR TREATING BACTERIAL INFECTIONS
CA2541380A1 (en) *	2003-10-10	2005-04-21	Multicell Technologies, Inc.	Use of cell lines to produce active therapeutic proteins
WO2005040222A1 (en) *	2003-10-16	2005-05-06	Bayer Healthcare Llc	Monoclonal antibodies for detection of urinary trypsin inhibitors
EP1586587A1 (en) *	2004-04-16	2005-10-19	Exonhit Therapeutics SA	Compositions and methods for detecting angiogenesis
CA2572455C (en)	2004-06-04	2014-10-28	Therasense, Inc.	Diabetes care host-client architecture and data management system
US7235530B2 (en)	2004-09-27	2007-06-26	Dyax Corporation	Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
BRPI0520032A2 (pt)	2005-02-18	2009-04-14	Angiochem Inc	moléculas para transportar um composto através da barreira hematoencefálica
US20090016959A1 (en) *	2005-02-18	2009-01-15	Richard Beliveau	Delivery of antibodies to the central nervous system
WO2007011693A2 (en) *	2005-07-14	2007-01-25	Medistem Laboratories, Inc.	Compositions of placentally-derived stem cells for the treatment of cancer
SI2233156T1 (sl)	2005-07-15	2013-09-30	Angiochem Inc.	Uporaba polipeptidov aprotinina kot nosilce v farmacevtskih konjugatih
US8093017B2 (en) *	2005-12-07	2012-01-10	Siemens Heathcare Diagnostics Inc.	Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
EP1981519B1 (en)	2005-12-29	2017-12-27	Dyax Corp.	Protease inhibition
US8063012B2 (en) *	2006-09-19	2011-11-22	Phylogica Limited	Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor
US20100063146A1 (en) *	2006-11-07	2010-03-11	Medof M Edward	Method for treating disorders related to complement activation
WO2008077478A1 (en) *	2006-12-22	2008-07-03	Bayer Schering Pharma Aktiengesellschaft	Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene
US9365634B2 (en)	2007-05-29	2016-06-14	Angiochem Inc.	Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2008154700A1 (en) *	2007-06-20	2008-12-24	Phylogica Limited	Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith
AU2008289005A1 (en) *	2007-08-21	2009-02-26	Genzyme Corporation	Treatment with kallikrein inhibitors
DE102007056231A1 (de)	2007-09-08	2009-03-12	Bayer Healthcare Ag	Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI)
JP5860698B2 (ja) *	2008-04-18	2016-02-16	アンジオケム，インコーポレーテッド	パクリタキセル、パクリタキセル類似体またはパクリタキセルコンジュゲートの医薬組成物ならびに関連する調製方法および使用方法
CN102245636A (zh)	2008-10-15	2011-11-16	安吉奥开米公司	用于药物递送的依托泊苷和多柔比星结合物
CA2740316A1 (en)	2008-10-15	2010-04-22	Angiochem Inc.	Conjugates of glp-1 agonists and uses thereof
AU2009322043A1 (en)	2008-12-05	2011-07-07	Angiochem Inc.	Conjugates of neurotensin or neurotensin analogs and uses thereof
AU2009327267A1 (en)	2008-12-17	2011-07-14	Angiochem, Inc.	Membrane type-1 matrix metalloprotein inhibitors and uses thereof
CN102307594A (zh)	2009-01-06	2012-01-04	戴埃克斯有限公司	用激肽释放酶抑制剂治疗粘膜炎
ES2729261T3 (es)	2009-04-20	2019-10-31	Angiochem Inc	Tratamiento del cáncer de ovario utilizando un agente anticancerígeno conjugado con un análogo de Angiopep-2
CA2766537A1 (en)	2009-07-02	2011-01-06	Angiochem Inc.	Multimeric peptide conjugates and uses thereof
SMT201800552T1 (it)	2010-01-06	2018-11-09	Dyax Corp	Proteine che legano la callicreina plasmatica
EP2371857A1 (en) *	2010-04-01	2011-10-05	CSL Behring GmbH	Factor XII inhibitors for treating interstitial lung disease
KR102320178B1 (ko)	2011-01-06	2021-11-02	다케다 파머수티컬 컴패니 리미티드	혈장 칼리크레인 결합 단백질
US10136845B2 (en)	2011-02-28	2018-11-27	Abbott Diabetes Care Inc.	Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
CA2839917A1 (en)	2011-06-24	2012-12-27	The Regents Of The University Of Colorado, A Body Corporate	Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
AU2013202648B2 (en)	2012-01-10	2016-05-19	Konkuk University	Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
EP2885318A4 (en)	2012-08-14	2016-03-30	Angiochem Inc	PEPTIDE DENDRIMER CONJUGATES AND ITS USES
MA39347B2 (fr)	2014-02-24	2020-05-29	Takeda Pharmaceuticals Co	Protéines de fusion d'uti
CA2942713A1 (en)	2014-03-27	2015-10-01	Dyax Corp.	Compositions and methods for treatment of diabetic macular edema
JP6823055B2 (ja)	2015-06-15	2021-01-27	アンジオケムインコーポレーテッド	軟髄膜癌腫症の治療方法
EA201891388A1 (ru)	2015-12-11	2018-11-30	Дайэкс Корп.	Ингибиторы калликреина плазмы и их применение для лечения обострения наследственного ангионевротического отека
CA3174478A1 (en)	2020-03-05	2021-09-10	DiaMedica USA Inc.	Ulinastatin polypeptides

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223482A (en)	1986-11-17	1993-06-29	Scios Nova Inc.	Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
US5106833A (en)	1987-07-23	1992-04-21	Washington University	Coagulation inhibitors
US5223409A (en)	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
US5663143A (en)	1988-09-02	1997-09-02	Dyax Corp.	Engineered human-derived kunitz domains that inhibit human neutrophil elastase
ES2066033T3 (es) *	1989-05-13	1995-03-01	Bayer Ag	Inhibidores de las proteinasas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK408089D0 (da)	1989-08-18	1989-08-18	Novo Nordisk As	Proteiner
ATE135044T1 (de)	1990-01-25	1996-03-15	Univ Washington	Faktor x-laci-hybridprotein
ES2124203T3 (es)	1991-03-01	2004-04-16	Dyax Corp.	Inhibidores de la elastasa neutrofila humana y la catepsina g humana.
RU2054180C1 (ru)	1991-08-21	1996-02-10	Жирнов Олег Петрович (н/п)	Способ лечения вирусных респираторных инфекций
IL104326A0 (en)	1992-01-07	1993-05-13	Novo Nordisk As	Variant of human kunitz-type protease inhibitor
IL104325A (en)	1992-01-07	2000-10-31	Novo Nordisk As	Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
JPH07509229A (ja)	1992-07-13	1995-10-12	コルバス・インターナショナル、インコーポレイテッド	ウシ膵トリプシン阻害因子から誘導される因子Ｘａの阻害因子
EP0740702A1 (en)	1992-12-02	1996-11-06	Zymogenetics, Inc.	Novel human amyloid protein precursor homologue and kunitz-type inhibitors
US5436153A (en)	1992-12-02	1995-07-25	Sprecher; Cindy A.	Human amyloid protein precursor homolog and Kunitz-type inhibitor
JP2769083B2 (ja)	1993-02-22	1998-06-25	日清食品株式会社	エラスターゼ阻害活性を有する新規ペプチドおよびその製造方法
US5455338A (en)	1993-11-05	1995-10-03	Zymogenetics, Inc.	DNA encoding novel human kunitz-type inhibitors and methods relating thereto
DE69533472T2 (de)	1994-01-11	2006-01-12	Dyax Corp., Cambridge	Kallikreinhemmende "kunitz-domäne"-proteine und derivaten davon
DK1489097T3 (da)	1994-01-11	2012-01-09	Dyax Corp	Hæmmere af humant plasmin, der er afledt af kunitz-domæner, og nukleinsyrer, der koder for samme
US5795954A (en)	1994-03-04	1998-08-18	Genentech, Inc.	Factor VIIa inhibitors from Kunitz domain proteins
WO1996003503A1 (fr)	1994-07-21	1996-02-08	The Green Cross Corporation	Procede de production d'un inhibiteur de la trypsine urinaire et des domaines de celui-ci, nouveau polypeptide associe et procede de production de ce polypeptide
US5541228A (en) *	1994-10-14	1996-07-30	Bristol-Myers Squibb Co.	Melatonergic agents
EP0827539A2 (en)	1995-05-08	1998-03-11	Scios Inc.	Kunitz type protease inhibitors
US5786328A (en)	1995-06-05	1998-07-28	Genentech, Inc.	Use of kunitz type plasma kallikrein inhibitors
EP0758682B1 (en)	1995-07-24	2004-05-12	Mitsubishi Chemical Corporation	Hepatocyte growth factor activator inhibitor
US5736364A (en)	1995-12-04	1998-04-07	Genentech, Inc.	Factor viia inhibitors
ES2263174T3 (es)	1996-03-11	2006-12-01	Bayer Corporation	Bikunina humana.
WO1998033920A2 (en)	1997-01-31	1998-08-06	Human Genome Sciences, Inc.	Tissue factor pathway inhibitor-3
US6294648B1 (en) *	1999-07-20	2001-09-25	Bayer Corporation	Protein having proteinase inhibitor activity

1997
- 1997-03-10 ES ES97915029T patent/ES2263174T3/es not_active Expired - Lifetime
- 1997-03-10 HU HU9902698A patent/HU226419B1/hu not_active IP Right Cessation
- 1997-03-10 DK DK97915029T patent/DK0891426T3/da active
- 1997-03-10 WO PCT/US1997/003894 patent/WO1997033996A2/en active IP Right Grant
- 1997-03-10 BR BR9708021A patent/BR9708021A/pt not_active Application Discontinuation
- 1997-03-10 YU YU8997A patent/YU8997A/sh unknown
- 1997-03-10 IL IL126115A patent/IL126115A/en not_active IP Right Cessation
- 1997-03-10 JP JP53280497A patent/JP3469584B2/ja not_active Expired - Fee Related
- 1997-03-10 PT PT97915029T patent/PT891426E/pt unknown
- 1997-03-10 CA CA002247888A patent/CA2247888A1/en not_active Abandoned
- 1997-03-10 TR TR1998/01794T patent/TR199801794T2/xx unknown
- 1997-03-10 AT AT97915029T patent/ATE328083T1/de not_active IP Right Cessation
- 1997-03-10 KR KR10-1998-0707163A patent/KR100356956B1/ko not_active Expired - Fee Related
- 1997-03-10 NZ NZ331540A patent/NZ331540A/en unknown
- 1997-03-10 PL PL97328822A patent/PL188387B1/pl not_active IP Right Cessation
- 1997-03-10 AU AU22077/97A patent/AU716923B2/en not_active Ceased
- 1997-03-10 DE DE69735996T patent/DE69735996T2/de not_active Expired - Fee Related
- 1997-03-10 EP EP97915029A patent/EP0891426B1/en not_active Expired - Lifetime
- 1997-03-11 SV SV1997000018A patent/SV1997000018A/es not_active Application Discontinuation
- 1997-03-11 ID IDP970779A patent/ID16224A/id unknown
- 1997-03-11 PA PA19978426301A patent/PA8426301A1/es unknown
- 1997-03-11 CO CO97013175A patent/CO4600683A1/es unknown
- 1997-03-11 IN IN601DE1997 patent/IN192874B/en unknown
- 1997-03-11 MY MYPI97001015A patent/MY120693A/en unknown
- 1997-03-11 AR ARP970100967A patent/AR006188A1/es active IP Right Grant
- 1997-03-11 HR HR970144A patent/HRP970144B1/xx not_active IP Right Cessation
1998
- 1998-08-31 US US09/144,428 patent/US6583108B1/en not_active Expired - Fee Related
2001
- 2001-10-10 US US09/974,026 patent/US7019123B2/en not_active Expired - Fee Related
2003
- 2003-04-23 JP JP2003119118A patent/JP2004000208A/ja active Pending
2006
- 2006-03-27 US US11/390,775 patent/US7452859B2/en not_active Expired - Fee Related
- 2006-04-20 AR ARP060101562A patent/AR053063A2/es unknown
2007
- 2007-01-11 AR ARP070100116A patent/AR058982A1/es unknown

Also Published As

Publication number	Publication date
AU2207797A (en)	1997-10-01
US20060172946A1 (en)	2006-08-03
AU716923B2 (en)	2000-03-09
KR100356956B1 (ko)	2003-03-15
ID16224A (id)	1997-09-11
DE69735996D1 (de)	2006-07-06
HUP9902698A2 (hu)	1999-11-29
JP2001521367A (ja)	2001-11-06
EP0891426B1 (en)	2006-05-31
PL328822A1 (en)	1999-02-15
AR053063A2 (es)	2007-04-18
HRP970144A2 (en)	1998-04-30
SV1997000018A (es)	1999-01-14
HRP970144B1 (en)	2004-10-31
WO1997033996A3 (en)	1997-11-13
HU226419B1 (en)	2008-12-29
AR006188A1 (es)	1999-08-11
US7452859B2 (en)	2008-11-18
IL126115A0 (en)	1999-05-09
PL188387B1 (pl)	2005-01-31
ATE328083T1 (de)	2006-06-15
AR058982A1 (es)	2008-03-05
JP3469584B2 (ja)	2003-11-25
US6583108B1 (en)	2003-06-24
DE69735996T2 (de)	2007-02-15
NZ331540A (en)	1999-10-28
BR9708021A (pt)	1999-07-27
US20030194398A1 (en)	2003-10-16
TR199801794T2 (xx)	2000-07-21
YU8997A (sh)	1999-09-27
JP2004000208A (ja)	2004-01-08
MY120693A (en)	2005-11-30
HUP9902698A3 (en)	2001-06-28
US7019123B2 (en)	2006-03-28
IL126115A (en)	2007-03-08
IN192874B (da)	2004-05-29
ES2263174T3 (es)	2006-12-01
WO1997033996A2 (en)	1997-09-18
EP0891426A2 (en)	1999-01-20
CA2247888A1 (en)	1997-09-18
PA8426301A1 (es)	2000-05-24
PT891426E (pt)	2006-10-31
CO4600683A1 (es)	1998-05-08
KR19990087697A (ko)	1999-12-27

Publication	Publication Date	Title
DK0891426T3 (da)	2006-10-02	Humant bikunin
DE69704309D1 (de)	2001-04-26	Verbinder
DE59710859D1 (de)	2003-11-20	Implantat
DE69705170D1 (de)	2001-07-19	Verbinder
NO971041D0 (no)	1997-03-06	Brönn-frakoplingsverktöy
FR2751867B1 (fr)	1999-05-21	Prothese collerette
DE69727611D1 (de)	2004-03-25	Organosiloxanzusammensetzungen
NO983266D0 (no)	1998-07-15	Distribuert Behandling
DE69517659D1 (de)	2000-08-03	Verbinder
ID21031A (id)	1999-04-08	Kornea buatan
DE69734745D1 (de)	2006-01-05	Verbinder
DE69523489D1 (de)	2001-12-06	Verbinder
DE69521660D1 (de)	2001-08-16	Verbinder
DK0832553T3 (da)	2002-05-06	Mejetærsker
DE69723647D1 (de)	2003-08-28	Verbinder
NO983263L (no)	1998-07-15	Distribuert behandling
DE69737872D1 (de)	2007-08-09	Verbinder
DE69705463D1 (de)	2001-08-09	Verbinder
DE69719872D1 (de)	2003-04-24	Verbinder
FR2749162B1 (fr)	1998-10-30	Prothese cotyloidienne
ATA91996A (de)	1998-11-15	Standseilbahn
DE69730547D1 (de)	2004-10-14	Verbinder
KR970053236U (ko)	1997-10-13	단추
KR970056592U (ko)	1997-11-10	단추
KR970054675U (ko)	1997-10-13	티슈용 케이스